
注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
凱萊英醫藥集團(天津)股份有限公司是一家主要從事藥物定制研發生產(CDMO)的中國公司。該公司的主營業務是化學藥物的工藝開發、放大和商業化,產品類別涵蓋多肽、寡核苷酸、單克隆抗體、抗體偶聯藥物和信使RNA等。該公司還從事藥物製劑解決方案、生物合成解決方案和臨床解決方案的提供。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Hao Hong | 69 | 2011 | Founder, Chairman & CEO |
Liang Hong | 50 | 2011 | Senior VP of Process Development & Application and Executive Director |
Rui Yang | 47 | 2011 | Co-CEO & Executive Director |
Stephen L. Buchwald | - | - | Member of Scientific Advisory Board |
Seble Wagaw | - | - | Member of Scientific Advisory Board |
Kar Chung Lee | 43 | 2021 | Independent Non Executive Director |
Phil S. Baran | 48 | - | Member of Scientific Advisory Board |
Ye Song | 64 | 2011 | Non-Executive Director |
Shanshan Di | 38 | 2017 | Shareholder representative Supervisor |
Xinxin Zhi | 44 | 2011 | Chairman of the Supervisory Committee |
Ting Zhang | 39 | 2021 | Non-Executive Director |
Da Zhang | 43 | 2018 | CFO, COO, Senior VP & Executive Director |
Patricia Alred | - | - | Member of Scientific Advisory Board |
Nicholas Turner | - | - | Member of Scientific Advisory Board |
Martin Eastgate | - | - | Member of Scientific Advisory Board |
Jin-Quan Yu | - | - | Member of Scientific Advisory Board |
Xuejiao Sun | 42 | 2023 | Independent Non-Executive Director |
Xinyi Hou | 64 | 2024 | Independent Non-Executive Director |
Timothy F. Jamison | - | - | Member of Scientific Advisory Board |
Stephane Caron | - | - | Member of Scientific Advisory Board |
Scott May | - | - | Member of Scientific Advisory Board |
Jingyi Hou | 41 | 2021 | Employee Representative Supervisor |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核